PMC:7589163 / 35271-35605 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T142","span":{"begin":145,"end":154},"obj":"Disease"},{"id":"T143","span":{"begin":318,"end":327},"obj":"Disease"}],"attributes":[{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A143","pred":"mondo_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Manaseki-Holland and colleagues evaluated the administration of a single high-dose (100,000 IU) vitamin D supplementation in addition to routine pneumonia treatment in children in Kabul, and evidenced a lower risk of recurrence in the intervention group but no difference in the time needed to recovery from the first infection [155]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T391","span":{"begin":64,"end":65},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T392","span":{"begin":201,"end":202},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Manaseki-Holland and colleagues evaluated the administration of a single high-dose (100,000 IU) vitamin D supplementation in addition to routine pneumonia treatment in children in Kabul, and evidenced a lower risk of recurrence in the intervention group but no difference in the time needed to recovery from the first infection [155]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T544","span":{"begin":96,"end":105},"obj":"Chemical"},{"id":"T545","span":{"begin":96,"end":103},"obj":"Chemical"},{"id":"T546","span":{"begin":248,"end":253},"obj":"Chemical"}],"attributes":[{"id":"A544","pred":"chebi_id","subj":"T544","obj":"http://purl.obolibrary.org/obo/CHEBI_27300"},{"id":"A545","pred":"chebi_id","subj":"T545","obj":"http://purl.obolibrary.org/obo/CHEBI_33229"},{"id":"A546","pred":"chebi_id","subj":"T546","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Manaseki-Holland and colleagues evaluated the administration of a single high-dose (100,000 IU) vitamin D supplementation in addition to routine pneumonia treatment in children in Kabul, and evidenced a lower risk of recurrence in the intervention group but no difference in the time needed to recovery from the first infection [155]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T76","span":{"begin":145,"end":154},"obj":"Phenotype"}],"attributes":[{"id":"A76","pred":"hp_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Manaseki-Holland and colleagues evaluated the administration of a single high-dose (100,000 IU) vitamin D supplementation in addition to routine pneumonia treatment in children in Kabul, and evidenced a lower risk of recurrence in the intervention group but no difference in the time needed to recovery from the first infection [155]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T225","span":{"begin":0,"end":334},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Manaseki-Holland and colleagues evaluated the administration of a single high-dose (100,000 IU) vitamin D supplementation in addition to routine pneumonia treatment in children in Kabul, and evidenced a lower risk of recurrence in the intervention group but no difference in the time needed to recovery from the first infection [155]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"950","span":{"begin":168,"end":176},"obj":"Species"},{"id":"958","span":{"begin":96,"end":105},"obj":"Chemical"},{"id":"966","span":{"begin":145,"end":154},"obj":"Disease"},{"id":"967","span":{"begin":318,"end":327},"obj":"Disease"}],"attributes":[{"id":"A950","pred":"tao:has_database_id","subj":"950","obj":"Tax:9606"},{"id":"A958","pred":"tao:has_database_id","subj":"958","obj":"MESH:D014807"},{"id":"A966","pred":"tao:has_database_id","subj":"966","obj":"MESH:D011014"},{"id":"A967","pred":"tao:has_database_id","subj":"967","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Manaseki-Holland and colleagues evaluated the administration of a single high-dose (100,000 IU) vitamin D supplementation in addition to routine pneumonia treatment in children in Kabul, and evidenced a lower risk of recurrence in the intervention group but no difference in the time needed to recovery from the first infection [155]."}